This trial is testing a new way to help people with HIV take their medication regularly, which could improve their health.
- Medication Adherence
2 Primary · 5 Secondary · Reporting Duration: Baseline, 1-, 3-, 6-, 12-, 18-, & 24-month follow-up interviews.
2 Treatment Groups
1 of 2
mHealth Facilitated Adherence Coaching
1 of 2
400 Total Participants · 2 Treatment Groups
Primary Treatment: Face-to-Face ART Adherence Intervention · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 5 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
What is the aggregate headcount of participants in this clinical experiment?
"That is accurate. According to clinicaltrials.gov, this medical trial first began recruiting patients on October 6th 2021 and was recently updated on December 13th 2021. Currently 400 participants are being sought from two different sites for the study." - Anonymous Online Contributor
Is the recruitment phase for this study still open?
"Affirmative, the clinicaltrials.gov page indicates that this medical experiment is presently recruiting patients. This trial was initially made available on October 6th 2021 and has been updated most recently on December 13th 2021. A total of 400 participants will be recruited from two separate locations for the study." - Anonymous Online Contributor
What are the anticipated outcomes of this experiment?
"This experiment's primary endpoint is the change in HIV Viral Load over a one-year period. Other secondary outcomes include Depressive Symptoms (measured by CESD with scores from 0 - 60), HIV Treatment Adherence Self-Efficacy (using HIV-ASES, 12 items in total), and HIV Stigma (via The HIV Stigma Scale, with values ranging from 40 - 160)." - Anonymous Online Contributor